Vland Selected as Top 100 Innovative Private Enterprises in Shandong

Qingdao Vland Biotech Inc. was selected as Top 100 Innovative Private Enterprises in Shandong (Ranked No.7) on July 26, 2024. And it ranked first among the shortlisted Qingdao-based enterprises.

Throughout the years, Vland has been committed to technological innovation with an increase in R&D investment. In 2023, the company's R&D investment accounted for 9.23% of its operating income, a relatively high level in the industry. From 2014 to 2023, the company's cumulative R&D investment accounted for 9.44% of its operating income.

Until now, Vland has established 8 technology centers and 2 labs. With the 8 nation-level innovation platforms and the IPD-based management platform, applicable research has been made in various sectors.

As of 2023, the company and its subsidiaries have been granted 390 authorized Chinese invention patents, 9 authorized U.S patents, 2 authorized European patents, 27 PCT international applications, and 39 new veterinary drug certificates (including 3 Class I new veterinary drugs).